FANCE Goat Polyclonal Antibody

CAT#: AP31970PU-N

FANCE goat polyclonal antibody, Aff - Purified



Need it in bulk or conjugated?
Get a free quote

CNY 5,371.00


货期*
4周

规格
    • 100 ug

Product images

Specifications

Product Data
Applications ELISA, IHC
Recommend Dilution
Peptide ELISA: 1/32000 (Detection limit). 
Western blot: Preliminary experiments gave an approx 70kDa band in Human Adipose and Uterus lysates after 0.1 µg/ml antibody staining.
Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 58.7kDa according to NP_068741.1. The 70kDa band was successfully blocked by incubation with the immunizing peptide. 

Immunohistochemistry on Paraffin Sections: 3-6 μg/ml. In paraffin embedded Human Placenta shows nuclear staining in some trophoblasts.
Reactivity Bovine, Human
Host Goat
Clonality Polyclonal
Immunogen Synthetic peptide from an internal region of Human FANCE (NP_068741.1).
Specificity This antibody detects FANCE.
Formulation Tris saline, pH~7.3
State: Aff - Purified
State: Liquid purified Ig fraction
Stabilizer: 0.5% BSA
Preservative: 0.02% Sodium Azide
Concentration lot specific
Purification Immunoaffinity Chromatography
Conjugation Unconjugated
Storage Condition

Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.

Gene Name Fanconi anemia complementation group E
Background FANCE promotes the nuclear accumulation of FANCC. FANCE protein is part of the FA nuclear complex, binding FANCC & FANCD2. It is required for the nuclear accumulation of FANCC and provides a bridge between the FA complex and FANCD2. FANCC mutants do not bind FANCE or prevent chromosome breakage.
Synonyms Fanconi anemia group E protein, FACE
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...